Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients

Clinical trial NCT00651612 · COMPLETED

Trial details

NCT number: NCT00651612
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2005-11-01
Primary completion: 2007-01-01
Enrollment: 604

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.